The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 5,201–5,300 of 31,469
Alebić, M. Š., Stojanović, N., Duhamel, A., & Dewailly, D. (2015) · Human Reproduction · doi:10.1093/humrep/dev131 · Cited by 67
Dib, R. E., Gameiro, O. L., Ogata, M. S. P., Módolo, N. S. P., Braz, L. G., Jorge, E. C., do Nascimento, P., & Beletate, V. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005525.pub3 · Cited by 71
Mechanisms of glucose intolerance in cystic fibrosis
Mohan, K., Miller, H., Dyce, P., Grainger, R., Hughes, R., Vora, J., Ledson, M., & Walshaw, M. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02738.x · Cited by 68
Boey, D., Heilbronn, L. K., Sainsbury, A., Laybutt, D. R., Kriketos, A. D., Herzog, H., & Campbell, L. V. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.08.002 · Cited by 68
Aller, R., de Luis, D. A., Fernández-Salazar, L. I., Calle, F., Velayos, B., Olcoz, J. L., Izaola, O., Sagrado, M. G., Conde, R., & González, J. M. D. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9981-3 · Cited by 65
Measures of insulin sensitivity.
Bloomgarden, Z. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.06.007 · Cited by 65
Dietary fibre consumption and insulin resistance – the role of body fat and physical activity
Breneman, C. B., & Tucker, L. A. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004953 · Cited by 67
El‐Shal, A. S., Shalaby, S. M., Aly, N. M., Rashad, N. M., & Abdelaziz, A. M. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2716-y · Cited by 67
The Mas receptor mediates modulation of insulin signaling by angiotensin-(1–7)
Muñoz, M. C., Giani, J. F., Burghi, V., Mayer, M. A., Carranza, A., Taira, C. A., & Dominici, F. P. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.04.001 · Cited by 67
GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women
Rudovich, N. N., Kaiser, S., Engeli, S., Osterhoff, M. A., Gögebakan, Ö., Blüher, M., & Pfeiffer, A. F. H. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.02.006 · Cited by 68
Daumit, G. L., Dalcin, A., Jerome, G. J., Young, D. R., Charleston, J. B., Crum, R. M., Anthony, C. B., Hayes, J., McCarron, P. B., Khaykin, E., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.224 · Cited by 68
Effects of a Three-Year Intervention
Bugge, A., El-Naaman, B., Dencker, M., Froberg, K., Holme, I., McMurray, R. G., & Andersen, L. B. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31824bd579 · Cited by 67
Maiztegui, B., Borelli, M. I., Madrid, V., Zotto, H. H. D., Raschia, M. A., Francini, F., Massa, M. L., Flores, L. E., Rebolledo, O. R., & Gagliardino, J. J. (2010) · Clinical Science · doi:10.1042/cs20100372 · Cited by 68
Visnegarwala, F., Chen, L., Raghavan, S. S., et al. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.06.001 · Cited by 67
Euthyroid Hyperthyrotropinemia in Children Born after in Vitro Fertilization
Sakka, S. D., Malamitsi‐Puchner, A., Loutradis, D., Chrousos, G. P., & Kanaka‐Gantenbein, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1624 · Cited by 67
Retinol‐binding Protein 4, Visceral Fat, and the Metabolic Syndrome: Effects of Weight Loss
Tschoner, A., Sturm, W., Engl, J., Kaser, S., Laimer, M. W., Laimer, E., Weiss, H. G., Patsch, J. R., & Ebenbichler, C. F. (2008) · Obesity · doi:10.1038/oby.2008.391 · Cited by 67
Zhao, Y., Yang, X., Ren, D., et al. (2014) · Food & Function · doi:10.1039/c3fo60707k · Cited by 67
Cuesta‐Sancho, S., Kireev, R. A., Garcı́a, C., Rancán, L., Vara, E., & Tresguerres, J. A. F. (2012) · AGE · doi:10.1007/s11357-012-9397-7 · Cited by 69
Ochoa, M. C., Santos, J. L., Azcona, C., Moreno-Aliaga, M. J., Martínez‐González, M. Á., Martínez, J. A., & Martí, A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.07.011 · Cited by 66
Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults
MacEneaney, O. J., Kushner, E. J., Guilder, G. P. V., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.262 · Cited by 69
Toms, T. E., Panoulas, V. F., Douglas, K., Nightingale, P., Smith, J., Griffiths, H. R., Sattar, N. A., Symmons, D. P. M., & Kitas, G. D. (2010) · Angiology · doi:10.1177/0003319710373749 · Cited by 67
Effects of medical therapies for acromegaly on glucose metabolism
Urbani, C., Sardella, C., Calevro, A., Rossi, G., Scattina, I., Lombardi, M., Lupi, I., Manetti, L., Martino, E., & Bogazzi, F. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0032 · Cited by 67
Steiropoulos, P., Παπάνας, Ν., Nena, E., Tsara, V., Fitili, C., Τzouvelekis, Α., Christaki, P. I., Maltezos, E. S., & Bouros, D. E. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.10.004 · Cited by 67
Effect of Marked Weight Loss on Adiponectin Gene Expression and Plasma Concentrations
Coughlin, C. C., Finck, B. N., Eagon, J. C., Halpin, V. J., Magkos, F., Mohammed, B. S., & Klein, S. (2007) · Obesity · doi:10.1038/oby.2007.556 · Cited by 67
Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS
Kaya, C., Cengiz, S. D., & Şatıroğlu, H. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.06.005 · Cited by 67
Association of Obstructive Sleep Apnea and Glucose Metabolism in Subjects With or Without Obesity
Kim, N. H., Cho, N. H., Yun, C., Lee, S. K., Yoon, D. W., Cho, H. J., Ahn, J. H., Seo, J. A., Kim, S. G., Choi, K. M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0375 · Cited by 72
Salicornia herbacea prevents high fat diet-induced hyperglycemia and hyperlipidemia in ICR mice
Park, S. H., Ko, S. K., Choi, J. G., & Chung, S. H. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02969402 · Cited by 67
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
Aller, R., de Luis, D. A., Izaola, O., Sagrado, M. G., Conde, R., Velasco, M. C., Alvarez, T., Pacheco, D., & González, J. M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0539-9 · Cited by 68
Guo, C.-R., Zhang, C.-F., Lu, L., Wang, Z., Xiao, W., & Yang, Z. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.02.007 · Cited by 68
Obese Adolescents Show Impaired Meal Responses of the Appetite‐Regulating Hormones Ghrelin and PYY
Mittelman, S. D., Klier, K., Braun, S., Azen, C. G., Geffner, M. E., & Buchanan, T. A. (2010) · Obesity · doi:10.1038/oby.2009.499 · Cited by 67
Nonalcoholic fatty liver disease in overweight children and adolescents
Sagi, R., Reif, S. S., Neuman, G., Webb, M., Phillip, M., & Shalitin, S. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00399.x · Cited by 65
Kim, S. W., Hur, W., Li, T. Z., et al. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.10 · Cited by 67
Effect of Different Doses of Aerobic Exercise Training on Total Bilirubin Levels
Swift, D. L., Johannsen, N. M., Earnest, C. P., Blair, S. N., & Church, T. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182357dd4 · Cited by 70
Fülöp, P., Seres, I., Lőrincz, H., Harangi, M., Somodi, S., & Paragh, G. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12282 · Cited by 68
Relationship between serum magnesium values, lipids and anthropometric risk factors
Randell, E. W., Mathews, M., Gadag, V. G., Zhang, H., & Sun, G. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.024 · Cited by 66
Tran, T. T., Gupta, N., Goh, T. T., Naigamwalla, D. Z., Chia, M. C., Koohestani, N., Mehrotra, S., McKeown‐Eyssen, G., Giacca, A., & Bruce, W. R. (2003) · PubMed · Cited by 67
Lin, R.-T., Tzeng, C., Lee, Y., Ho, W., Cheng, J., Lin, J., & Chang, S. (2009) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-9-26 · Cited by 67
Mazokopakis, E. E., Papadomanolaki, M. G., Fousteris, A. A., Kotsiris, D. A., Lampadakis, I., & Ganotakis, E. S. (2014) · Europe PMC (PubMed Central) · Cited by 67
Engström, B. E., Burman, P., Holdstock, C., Öhrvall, M., Sundbom, M., & Karlsson, F. A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02069 · Cited by 67
Palomba, S., Falbo, A. I., Russo, T., Orio, F., Tolino, A., & Zullo, F. (2010) · Human Reproduction · doi:10.1093/humrep/dep466 · Cited by 67
Veltman-Verhulst, S. M., van Haeften, T. W., Eijkemans, M. J. C., de Valk, H. W., Fauser, B. C. J. M., & Goverde, A. J. (2010) · Human Reproduction · doi:10.1093/humrep/deq272 · Cited by 66
Cedernaes, J., Lampola, L., Axelsson, E. K., Liethof, L., Hassanzadeh, S., Yeganeh, A., Broman, J., Schiöth, H. B., & Benedict, C. (2015) · Journal of Sleep Research · doi:10.1111/jsr.12340 · Cited by 69
Vitoratos, N., Valsamakis, G., Mastorakos, G. P., Boutsiadis, A., Salakos, N., Kouskouni, E., & Creatsas, G. K. (2008) · HORMONES · doi:10.14310/horm.2002.1202 · Cited by 68
Cubbon, R. M., Murgatroyd, S. R., Ferguson, C., Bowen, T. S., Rakobowchuk, M., Baliga, V., Cannon, D. T., Rajwani, A., Abbas, A., Kahn, M., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.201012 · Cited by 69
Laukkanen, J. A., Mäkikallio, T. H., Ronkainen, K., Karppi, J., & Kurl, S. (2012) · Diabetes Care · doi:10.2337/dc12-0110 · Cited by 68
A Possible Link Between Skeletal Muscle Mitochondrial Efficiency and Age-Induced Insulin Resistance
Iossa, S., Mollica, M. P., Lionetti, L., Crescenzo, R., Tasso, R., & Liverini, G. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2861 · Cited by 69
Sommese, L. M., Valverde, C. A., Blanco, P. G., Castro, M. C., Rueda, J. O. V., Kaetzel, M. A., Dedman, J. R., Anderson, M. E., MATTIAZZI, A. R., & Palomeque, J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.022 · Cited by 67
Ding, Y., Zhang, Z., Dai, X., Jiang, Y., Bao, L., Li, Y., & Li, Y. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-51 · Cited by 67
Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial
Hughes, T. M., Althouse, A. D., Niemczyk, N. A., Hawkins, M., Kuipers, A. L., & Sutton‐Tyrrell, K. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-114 · Cited by 66
Baba, T., Endo, T., Ikeda, K., Shimizu, A., Honnma, H., Ikeda, H., Masumori, N., Ohmura, T., Kiya, T., Fujimoto, T., et al. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02252.x · Cited by 67
Yang, M. H., Sung, J., & Gwak, G. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.11.017 · Cited by 67
Engel, S., & Tholstrup, T. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112227 · Cited by 71
Barrea, L., Somma, C. D., Macchia, P. E., Falco, A., Savanelli, M. C., Orio, F., Colao, A., & Savastano, S. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.12.007 · Cited by 67
Gao, X., Zhang, W., Wang, Y., Pedram, P., Cahill, F., Zhai, G., Randell, E. W., Gulliver, W. P., & Sun, G. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0095-9 · Cited by 66
Kim, J. D., Kang, S. J., Lee, M. K., Park, S. E., Rhee, E., Park, C., Oh, K. W., Park, S. W., & Lee, W. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.320 · Cited by 70
Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development
Liu, J., Zou, W., Chen, S.-J., Wei, H., Yin, Y., Zou, Y.-Y., & Lu, F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i32.7353 · Cited by 67
Sharma, S., Pathak, S., Gupta, G., Sharma, S. K., Singh, L., Sharma, R. K., Mishra, A., & Dua, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.048 · Cited by 67
Joo, S. K., Kim, W. K., Kim, D., Kim, J. H., Oh, S., Lee, K. L., Chang, M. S., Jung, Y. J., So, Y. H., Lee, M. S., et al. (2017) · Liver International · doi:10.1111/liv.13549 · Cited by 67
Bharath, L. P., Choi, W. W., Cho, J.-M., Skobodzinski, A. A., Wong, A., Sweeney, T. E., & Park, S. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-018-3898-8 · Cited by 72
Zhu, X., Ouyang, W., Lan, Y., Xiao, H., Tang, L., Liu, G., Feng, K., Zhang, L., Song, M., & Cao, Y. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100574 · Cited by 76
Assessment of insulin sensitivity in glucokinase-deficient subjects
Clément, K., Pueyo, M. E., Vaxillaire, M., Rakotoambinina, B., Thuillier, F., Passa, P., Froguel, P., Robert, J., & Velho, G. (1996) · Diabetologia · doi:10.1007/bf00400417 · Cited by 66
Reduced levels of adiponectin in sleep apnea syndrome
Masserini, B., Morpurgo, P. S., Donadio, F., Baldessari, C., Bossi, R., Beck‐Peccoz, P., & Orsi, E. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344179 · Cited by 67
Κousta, E., Lawrence, N. J., Godsland, I. F., Penny, A., Anyaoku, V., Millauer, B. A., Cela, E., Johnston, D. G., Robinson, S., & McCarthy, M. I. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01820.x · Cited by 67
Atabek, M. E., Pirgon, Ö., & Kıvrak, A. S. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e318030d206 · Cited by 67
Cutfield, W. S., Lindberg, A., Rapaport, R., Wajnrajch, M. P., & Saenger, P. H. (2006) · Hormone Research in Paediatrics · doi:10.1159/000091719 · Cited by 67
Colao, A., Spiezia, S., Somma, C. D., Pivonello, R., Marzullo, P., Rota, F., Musella, T., Auriemma, R. S., Martino, M. C. D., & Lombardi, G. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347225 · Cited by 67
The role of PPARγ in high-fat diet-induced obesity and insulin resistance
Kadowaki, T., Hara, K., Kubota, N., Tobe, K., Terauchi, Y., Yamauchi, T., Eto, K., Kadowaki, H., Noda, M., Hagura, R., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00206-9 · Cited by 69
Pergola, G. D., Pannacciulli, N., Ciccone, M. M., Tartagni, M., RIZZON, P., & GIORGINO, R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802292 · Cited by 67
Melenovský, V. (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)00142-4 · Cited by 67
Colberg, S. R., Somma, C. T., & Sechrist, S. R. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.03.014 · Cited by 67
Lower Serum Adiponectin Levels in African‐American Boys
Degawa‐Yamauchi, M., Dilts, J. R., Bovenkerk, J. E., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.187 · Cited by 67
Insulin Resistance Precedes Weight Loss in Adults without Diabetes : The Rancho Bernardo Study
Wedick, N. M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.12.1199 · Cited by 68
Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families
Hager, J., Zouali, H., Velho, G., & Froguel, P. (1993) · The Lancet · doi:10.1016/0140-6736(93)92793-s · Cited by 67
Derosa, G., Cicero, A. F. G., D’Angelo, A., Gaddi, A. V., Ciccarelli, L., Piccinni, M. N., SALVADEO, S. A. T., PRICOLO, F., Ferrari, I., Gravina, A., et al. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.05.012 · Cited by 67
Chang, S. A., Kim, H. S., Yoon, K. H., Ko, S. H., Kwon, H. S., Kim, S. R., Lee, W. C., Yoo, S. J., Son, H. S., Cha, B. Y., et al. (2004) · Metabolism · doi:10.1016/s0026-0495(03)00314-7 · Cited by 66
Miller, K. K., Wexler, T., Fazeli, P., Gunnell, L., Graham, G. J., Beauregard, C., Hemphill, L., Nachtigall, L., Loeffler, J., Swearingen, B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1611 · Cited by 66
Rebelos, E., Rinne, J. O., Nuutila, P., & Ekblad, L. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071532 · Cited by 66
“In cognitively normal elderly individuals with newly diagnosed diabetes or prediabetes, IR, measured with the homeostasis model of IR(HOMA-IR) [89] was associated with reduced cerebral metabolic rate of glucose in regions where hypometabolism is seen also in AD, i.”
MethodForslund, M., Landin-Wilhelmsen, K., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoz042 · Cited by 66
“Insulin sensitivity was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR), calculated as fasting insulin (μU/L) × fasting glucose (nmol/L)/22.5 (Matthews et al., 1985).”
MethodInfluentialMoran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2336 · Cited by 66
The Frequency of Elevated Blood Pressure in Obese Minority Youth
Puri, M., Flynn, J. T., Garcia, M., Nussbaum, H., Freeman, K. D., & DiMartino-Nardi, J. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07285.x · Cited by 66
Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis
Alsanea, S., Gao, M., & Liu, D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0053-0 · Cited by 67
Murata, Y., Kadoya, Y., Yamada, S., & Sanke, T. (2017) · Diabetology International · doi:10.1007/s13340-017-0339-6 · Cited by 66
Mohamed, W., & Schaalan, M. F. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0390-x · Cited by 67
Willems, A. E. M., Jong, M. S., van Beek, A. P., Nederhof, E., & van Dijk, G. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa044 · Cited by 67
Tricò, D., Moriconi, D., Berta, R. D., Baldi, S., Quiñones-Galvan, A., Guiducci, L., Taddei, S., Mari, A., & Nannipieri, M. (2021) · Nutrients · doi:10.3390/nu13041345 · Cited by 72
Sokooti, S., Flores-Guerrero, J. L., Heerspink, H. J. L., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01348-w · Cited by 69
van Galen, K. A., Schrantee, A., ter Horst, K. W., la Fleur, S. E., Booij, J., Constable, R. T., Schwartz, G. J., Dileone, R., & Serlie, M. J. M. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00816-9 · Cited by 67
Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation
Li, F., Armet, A. M., Korpela, K., Liu, J., Quevedo, R. M., Asnicar, F., Seethaler, B., Rusnak, T., Cole, J. L., Zhang, Z., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.034 · Cited by 77
Ou, H., Yang, Y., Wu, H., Wu, J., Lu, F., & Chang, C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04070.x · Cited by 66
Burke, L. E., Hudson, A. G., Warziski, M. T., Styn, M. A., Music, E., Elci, O. U., & Sereika, S. M. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.588 · Cited by 66
Joseph, J. J., Wang, X., Spanakis, E. K., Seeman, T. E., Wand, G. S., Needham, B. L., & Golden, S. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.021 · Cited by 68
Miller, M. B., Pearcey, G. E. P., Cahill, F., McCarthy, H., Stratton, S. B. D., Noftall, J. C., Buckle, S., Basset, F. A., Sun, G., & Button, D. C. (2014) · BioMed Research International · doi:10.1155/2014/191797 · Cited by 68
Shargorodsky, M., Boaz, M., Goldberg, Y., Matas, Z., Gavish, D., Fux, A., & Wolfson, N. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.37 · Cited by 66
Diet, Exercise, and Endothelial Function in Obese Adolescents
Bruyndonckx, L., Hoymans, V. Y., Guchtenaere, A. D., Helvoirt, M. V., Craenenbroeck, E. M. V., Frederix, G., Lemmens, K., Vissers, D. K., Vrints, C. J., Ramet, J., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-1577 · Cited by 66
Song, S., Zhang, L., Zhang, H., Wei, W., & Jia, L. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110403728 · Cited by 66
Laimer, M. W., Kaser, S., Kranebitter, M., Sandhofer, A., Mühlmann, G., Schwelberger, H. G., Weiss, H., Patsch, J. R., & Ebenbichler, C. F. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802897 · Cited by 65
Yamaguchi, T., Kanazawa, I., Takaoka, S., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.003 · Cited by 66
Frantz, E. D. C., Crespo-Mascarenhas, C., Vianna, A. R. D. C. B., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067192 · Cited by 66
Sustained Delivery of IL-1Ra from PF127-Gel Reduces Hyperglycemia in Diabetic GK-Rats
Akash, M. S. H., Rehman, K., Sun, H., & Chen, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055925 · Cited by 68
Zoth, N., Weigt, C., Laudenbach-Leschowsky, U., & Diel, P. R. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.029 · Cited by 66
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
